Vitrase Solution For Injection 200Uspu Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Vitrase: Solution for injection (200USPu)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

HYALURONIDASE (hye al ur ON i dase) is a natural protein. It is used to improve the effects of other injectable medicines given with this medicine.

In-Depth Information
Select a Medication

Vitrase 200USP units/mL Solution for Injection

NDC: 242080002
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Urography, Hypodermoclysis

Sometimes used for but not FDA approved for the following conditions:
Vitreous Hemorrhage, Local Anesthesia, Extravasation, Ophthalmic Anesthesia, Infiltration Anesthesia, Diabetic Retinopathy

Storage Information
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Store unopened containers in refrigerator (36 to 46 degrees F)
Do not freeze
Vitrase 200USP units/mL Solution for Injection

Reported Side Effects for Vitrase 200USP units/mL Solution for Injection

Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Vitrase

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5